CGH 停用依木兰对谷浓度无影响.pdf

Accepted Manuscript Withdrawal of Immunomodulators After Co-treatment Does not Reduce Trough Level of Infliximab in Patients with Crohn’s Disease David Drobne, Peter Bossuyt, Christine Breynaert, Tom Cattaert, Niels Vande Casteele, Griet Compernolle, Matthias Jürgens, Marc Ferrante, Vera Ballet, Willem- Jan Wollants, Isabelle Cleynen, Kristel Van Steen, Ann Gils, Paul Rutgeerts, Severine Vermeire, Gert Van Assche PII: S1542-3565(14)01072-6 DOI: 10.1016/j.cgh.2014.07.027 Reference: YJCGH 53908 To appear in: Clinical Gastroenterology and Hepatology Accepted Date: 15 July 2014 Please cite this article as: Drobne D, Bossuyt P, Breynaert C, Cattaert T, Vande Casteele N, Compernolle G, Jürgens M, Ferrante M, Ballet V, Wollants W-J, Cleynen I, Van Steen K, Gils A, Rutgeerts P, Vermeire S, Van Assche G, Withdrawal of Immunomodulators After Co-treatment Does not Reduce Trough Level of Infliximab in Patients with Crohn’s Disease, Clinical Gastroenterology and Hepatology (2014), doi: 10.1016/j.cgh.2014.07.027. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. All studies published in Clinical Gastroenterology and Hepatology are embargoed until 3PM ET of the day they are published as corrected proofs on-line. Studies cannot be publicized as accepted manuscripts or uncorrected proofs. ACCEPTED MANUSCRIPT 1 TITLE: Withdrawal of Immunomodulators After Co-treatment Does not Reduce 2 Trough Level of Infliximab in Patients with Crohn’s Disease 3 4 5 SHORT TITLE: AZAT